Infusion Therapies Offered

Mount Sinai’s Therapeutic Infusion Center provides the following infusion therapies:

  • Abatacept (Orencia)
  • Adalimumab (Humira)
  • Alemtuzumab ( Lemtrada )
  • Belatacept (Nulojix)
  • Belimumab (Benlysta)
  • Benralizumab (Fasenra)
  • C1 Esterase Inhibitor (Berinert, Ruconest)
  • Certolizumab pegol (Cimzia)
  • Cyclophosphamide (Cytoxan)
  • Denosumab (Prolia)
  • Golimumab (Simponi)
  • Infliximab (Remicade)
  • Intravenous Immune Globulin [IVIG] (Gamunex-C, Gammagard, Gammagard S/D)
  • Iron infusions (Ferrlecit, Venofer, Injectafer)
  • Lanreotide (Somatuline Depot)
  • Mepolizumab (Nucala)
  • Natalizumab (Tysabri)
  • Ocrelizumab (Ocrevus)
  • Octreotide (Sandostatin LAR Depot)
  • Omalizumab (Xolair)
  • Pegloticase (Krystexxa)
  • Reslizumab (Cinqair)
  • Rituximab (Rituxan)
  • Tocilizumab (Actemra)
  • Ustekinumab (Stelara IV and SQ)
  • Vedolizumab (Entyvio)
  • Zoledronic Acid Injection (Reclast)